Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cooper Companies, Allergan, B&L Provide Investors With Clear Vision In 1999

This article was originally published in The Gray Sheet

Executive Summary

The ability of the Cooper Companies to build market share in the high-margin toric contact lens sector of the specialty lens market while successfully transforming itself from a health conglomerate into a more focused ophthalmic concern helped focus investors attention and lift the firm's stock price significantly in 1999.

You may also be interested in...



Summit's Integrated Wavefront Technology To Break In 2001

Summit Technology, backed by encouraging results from 20 patients treated thus far in an ongoing feasibility trial, is hoping to market a customized refractive laser surgical system integrating the company's CustomCornea wavefront measuring device with its LADARVision system by the end of 2001.

Summit's Integrated Wavefront Technology To Break In 2001

Summit Technology, backed by encouraging results from 20 patients treated thus far in an ongoing feasibility trial, is hoping to market a customized refractive laser surgical system integrating the company's CustomCornea wavefront measuring device with its LADARVision system by the end of 2001.

J&J Professional Division Is Device Industry's Unsung Hero In 1999

Johnson & Johnson's commitment to expanding its medical device business, combined with success in executing and managing drug and device acquisitions, made the company one of the few bright lights among large-cap medical device industry issues in 1999.

UsernamePublicRestriction

Register

OM016204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel